Marsh & McLennan Companies, Inc. (MRSH) — Fair Value Analysis
Base-case fair value (P50): $146.69 · Current price: $168.68 · Verdict: Fairly Valued
The Verdict on MRSH
Marsh & McLennan Companies (MRSH), a key player in the Financial Services sector, currently trades at $168.68. Based on our proprietary Monte Carlo simulations, the stock is assessed as "Fairly Valued." Our models calculate a median fair value (P50) for MRSH at $146.69. This indicates that the current market price of $168.68 is above this central fair value estimate, translating to an implied -13.0% against the P50. Despite the current price trading above the median estimate, the overall verdict points to a balanced valuation rather than strong overvaluation, suggesting the market largely prices in its intrinsic worth.
How MRSH stacks up against Financial Services
Within the competitive Financial Services sector, MRSH's operational and financial health currently holds an "unrated" quality tier. This designation means that while our Monte Carlo fair value analysis provides a robust intrinsic assessment, a definitive comparative standing against sector peers based on our specific quality metrics is not yet available. The relationship between $168.68 and the calculated $146.69 offers a crucial perspective on MRSH's valuation profile, even without a specific quality rating. Investors should consider this "unrated" status when evaluating the "Fairly Valued" verdict, recognizing the intrinsic valuation stands on its own.
What this means for investors
For investors assessing MRSH, the "Fairly Valued" verdict, accompanied by the -13.0% relative to a median fair value of $146.69 against the current price of $168.68, suggests a nuanced investment posture. While our simulations explore a wide array of outcomes, the primary P50 target indicates that a substantial immediate upside from this fair value estimate may not be apparent. The Monte Carlo simulation rigorously analyzes thousands of forward-looking scenarios to arrive at this $146.69. Investors interested in understanding the full distribution of potential price outcomes, including detailed downside and bull-case scenarios beyond the median, will find deeper insights. Sign up for FairCurve to see the full bear/bull distribution and track MRSH's fair value as new fundamentals are released.
Frequently Asked Questions
Is MRSH overvalued or undervalued right now?
Based on our Monte Carlo simulations, Marsh & McLennan Companies (MRSH) is assessed as "Fairly Valued." The current price of $168.68 is above the median fair value (P50) of $146.69.
What is the bear case and bull case for MRSH?
A comprehensive understanding of MRSH's bear case (P10) and bull case (P90) targets, along with the probability of achieving upside scenarios, is available to FairCurve account holders. These detailed percentile distributions are integral to our Monte Carlo analysis but are not publicly disclosed with specific dollar values.
How does FairCurve calculate MRSH's fair value?
FairCurve calculates MRSH's fair value using advanced Monte Carlo simulations. This involves running thousands of forward-looking scenarios to project potential financial outcomes and determine a probabilistic fair value range.
How can I track MRSH's fair value as it changes?
You can easily track MRSH's fair value by adding it to your watchlist in a free FairCurve account. This provides daily fair value updates and instant re-valuation whenever new fundamental data, such as earnings reports, are released.